You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Cardiovasc. Med., 24 August 2022

Sec. Structural Interventional Cardiology

Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.952331

Corrigendum: Safety and efficacy of contemporary drug-eluting stents in patients with ST-segment elevation myocardial infarction and a high ischemic risk

On behalf of The KAMIR-NIH Investigators
  • 1. Yonsei University College of Medicine Cardiovascular Center, Yongin Severance Hospital, Yongin-si, South Korea

  • 2. Data Science Team (Biostatistician), Center for Digital Health, Yongin Severance Hospital, Yongin-si, South Korea

  • 3. Department of Statistics, Keimyung University, Daegu, South Korea

  • 4. Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea

  • 5. Chonnam National University Hospital and Medical School, Gwangju, South Korea

  • 6. Department of Cardiology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si, South Korea

Article metrics

View details

901

Views

519

Downloads

In the published article, there was an error in affiliation 5. Instead of “Chonnam National University Hospital, Gwangju, South Korea,” it should be “Chonnam National University Hospital and Medical School, Gwangju, South Korea.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

ST-segment elevation myocardial infarction, drug-eluting stent, percutaneous coronary intervention (PCI), target lesion failure, high risk factor

Citation

Lee O-H, Kim Y, Son N-H, Cho D-K, Kim J-S, Kim B-K, Choi D, Hong M-K, Jeong MH and Jang Y (2022) Corrigendum: Safety and efficacy of contemporary drug-eluting stents in patients with ST-segment elevation myocardial infarction and a high ischemic risk. Front. Cardiovasc. Med. 9:952331. doi: 10.3389/fcvm.2022.952331

Received

25 May 2022

Accepted

11 August 2022

Published

24 August 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

9 - 2022

Updates

Copyright

*Correspondence: Myung Ho Jeong

†These authors have contributed equally to this work

This article was submitted to Structural Interventional Cardiology, a section of the journal Frontiers in Cardiovascular Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics